KW-136 with Sofosbuvir

· Kawin Technology Share-holding Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KW-136 with Sofosbuvir, covering 2019-06-25 to 2019-06-25. Get the full timeline:

Most recent: Clinical Trial Update: KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis C [Phase 3]